Tag Archives: big pharma news

Teva faces $100M lawsuit from Israel over unpaid Copaxone royalties: report

Teva Pharmaceuticals’ big-selling multiple sclerosis drug Copaxone is losing ground in the U.S. thanks to generics, but the medicine was once the company’s primary growth driver. Now, it’s at the center of a lawsuit filed by the state of Israel over alleged unpaid royalties.

Israel has sued Teva for $100 million in royalties on the longer-lasting version of the medicine, Globes reports. While Teva owns Copaxone marketing rights, scientists at the Weizmann Institute of Science developed the medicine, the publication reports. 

When the original daily version, first approved in the U.S. in 1996, neared its patent expiration, the company switched its efforts to a longer-acting version. In its lawsuit, Israel claims government scientists at the Weizmann Institute developed the long-acting version as well, so it’s owed royalties.

“The state has no alternative but to take legal action against Teva to ensure that it receives suitable remuneration for using public resources that brought Teva very large scale revenue,” the suit says, according to Globes. 

READ FULL

Judge clears way for San Francisco’s ‘public nuisance’ opioid lawsuit to go to trial

Defendants, including Walgreens, Endo Pharmaceuticals and Teva Pharmaceuticals had tried to get the case thrown out.

(CN) — A federal judge on Thursday cleared the way for San Francisco’s opioid lawsuit against Walgreens and a number of pharmaceutical companies to head to trial, which is set to begin on April 25.

Thousands of states, cities and counties have sued pharmaceutical companies over their role in the opioid epidemic, which is believed to have been caused by the marketing and overprescription of prescription drugs like Oxycontin. Many patients who were prescribed an opiate later switched over to using illegal narcotics like heroin. According to the CDC, nearly half a million people died from opiate overdoses between 1999 and 2019.

The biggest culprit was Purdue Pharma, which manufactured and marketed Oxycontin, and which entered bankruptcy in 2020. That proceeding hit the pause button on all lawsuits against Purdue, and eventually lead to a massive settlement, in which cities and states will effectively take over ownership of Purdue. The former owners of the company, the Sackler family, contributed $6 billion to the settlement, a good deal of which went to the governmental entities, in exchange for immunity from future lawsuits.

The drugmaker Johnson & Johnson and three pharmaceutical distributors agreed to a $26 billion settlement with states and municipalities in February.

Read Full

Moderna Faces Patent Lawsuit on Covid-19 Vaccine

Two small biotech firms filed a long-awaited lawsuit against Moderna, alleging that its Covid-19 vaccine infringes on a number of patents they control.

The companies, Arbutus Biopharma and Genevant Sciences, a subsidiary of Roivant Sciences, say that they hold patents covering the lipid nanoparticle wrappers used to carry the messenger RNA in Moderna‘s (ticker: MRNA) Covid-19 vaccine through the bloodstream and into the cells.

READ FULL

Biden pushes to end ban on negotiating Medicare drug prices; Big Pharma pushes back

Undoing the ban is the linchpin of President Joe Biden’s healthcare agenda. It would mean lower costs, with savings put into things such as dental coverage for retirees.

As a participant in Medicare’s prescription drug program, Florida retiree Donna Weiner would like to pay less for her medicines, which cost her about $6,000 a year.

And as a retired accountant who spent 50 years handling the books for companies, she sees a way to get there.

“You know from working in a business that it makes no sense for an administrator of a plan or a company not to be involved in what they have to pay out,” said Weiner, who lives in Longwood, Florida, near Orlando.

For Medicare “to negotiate those prices down would be thousands of dollars back in my pocket every year,” she said.

Read Full

Scott, Campbell counties hop on board Big Pharma racketeering lawsuit train


Two East Tennessee counties are now on board to join a growing and fast-moving national effort to use federal racketeering laws to hold drug makers, distributors and dispensers accountable for creating and fostering the opioid epidemic in the United States, records show.

Government leaders in Campbell and Scott Counties have authorized the filing of lawsuits in U.S. District Court against the firms that make, distribute and dispense opiate prescription painkillers.

The law firm Jessee & Jessee filed the first such legal action in the federal Eastern District of Tennessee on behalf of Campbell County earlier this year. The law firms Lieff Cabraser Heimann & Bernstein and Taylor & Knight filed a similar action on behalf of Scott County late last week.

Full Read – https://www.knoxnews.com/story/news/crime/2018/03/06/scott-campbell-counties-opioid-epidemic-big-pharma-racketeering-lawsuits/399172002/